(Q44372688)

2 December 2017

Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease (English)

1 reference

2 December 2017

Geoffrey W Chan

1

1 reference

2 December 2017

Gullu Gorgun

series ordinal

2

1 reference

2 December 2017

Kenneth B Miller

series ordinal

3

1 reference

2 December 2017

Francine M Foss

series ordinal

4

1 reference

2 December 2017

1 March 2003

1 reference

Biology of Blood and Marrow Transplantation

2 December 2017

1 reference

2 December 2017

9

1 reference

2 December 2017

3

1 reference

2 December 2017

170-176

1 reference

Bone marrow transplantation

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970006-8

7 January 2021

Graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970006-8

7 January 2021

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970006-8

7 January 2021

Hematopoietic stem cell transplants after reduced intensity conditioning regimen (RI-HSCT): report of a workshop of the European group for Blood and Marrow Transplantation (EBMT).

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970006-8

7 January 2021

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970006-8

7 January 2021

Nonmyeloablative allogeneic stem cell transplant strategies and the role of mixed chimerism

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970006-8

7 January 2021

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970006-8

7 January 2021

Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970006-8

7 January 2021

High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970006-8

7 January 2021

The immunopathophysiology of acute graft-versus-host-disease

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970006-8

7 January 2021

Selective T-cell subset ablation demonstrates a role for T1 and T2 cells in ongoing acute graft-versus-host disease: a model system for the reversal of disease

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970006-8

7 January 2021

Adjusted-dose continuous-infusion cyclosporin A to prevent graft-versus-host disease following allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970006-8

7 January 2021

Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970006-8

7 January 2021

Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970006-8

7 January 2021

The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970006-8

7 January 2021

Prevention of graft versus host disease by inactivation of host antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970006-8

7 January 2021

Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970006-8

7 January 2021

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970006-8

7 January 2021

Dendritic cell lineage, plasticity and cross-regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970006-8

7 January 2021

Reciprocal control of T helper cell and dendritic cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970006-8

7 January 2021

Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970006-8

7 January 2021

Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970006-8

7 January 2021

Immunomodulatory effects of extracorporeal photochemotherapy in patients with extensive chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970006-8

7 January 2021

10.1016/S1083-8791(03)70006-8

Identifiers

DOI

1 reference

2 December 2017

1 reference